Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561652184> ?p ?o ?g. }
- W2561652184 endingPage "202" @default.
- W2561652184 startingPage "191" @default.
- W2561652184 abstract "To determine the comparative efficacy and safety of antipsychotics for youth with early-onset schizophrenia using network meta-analytic methods combining direct and indirect trial data.The authors systematically searched MEDLINE, the Cochrane Library, and clinicaltrials.gov and selected randomized controlled trials allocating youth with schizophrenia spectrum disorders to a (non-clozapine) antipsychotic versus placebo or another antipsychotic. Major efficacy outcomes were Positive and Negative Syndrome Scale (PANSS) total and positive symptoms. Major safety outcomes were weight, plasma triglyceride levels, extrapyramidal symptoms, akathisia, and all-cause discontinuation. Sixteen additional outcomes were analyzed. A random-effects arm-based network meta-analysis was applied, and consistency was assessed by pairwise meta-analysis. Confidence in PANSS total estimates was assessed by applying the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.Twelve 6- to 12-week trials (N = 2,158; 8-19 years old; 61% boys) involving 8 antipsychotics (aripiprazole, asenapine, paliperidone, risperidone, quetiapine, olanzapine, molindone, and ziprasidone) were analyzed. PANSS total symptom change was comparable among antipsychotics (low- to moderate-quality evidence), except ziprasidone (very low- to low-quality evidence), and all antipsychotics were superior to placebo (low- to high-quality evidence), except ziprasidone and asenapine (low- to moderate-quality evidence). PANSS positive changes and additional efficacy outcomes were comparable among antipsychotics. Weight gain was primarily associated with olanzapine; extrapyramidal symptoms and akathisia were associated with molindone; and prolactin increased with risperidone, paliperidone, and olanzapine. Serious adverse events, discontinuation of treatment, sedation, insomnia, or change in triglycerides did not differ among antipsychotics.This network meta-analysis showed comparable efficacy among antipsychotics for early-onset schizophrenia, except that efficacy appeared inferior for ziprasidone and unclear for asenapine. Adverse reaction profiles varied substantially among the investigated antipsychotics and were largely consistent with prior findings in adults. Protocol registration information-Antipsychotic Treatment for Children With Schizophrenia Spectrum Disorders: Network Meta-Analysis of Randomised Trials; https://www.crd.york.ac.uk/PROSPERO/; CRD42013006676." @default.
- W2561652184 created "2017-01-06" @default.
- W2561652184 creator A5001609083 @default.
- W2561652184 creator A5003878022 @default.
- W2561652184 creator A5013953628 @default.
- W2561652184 creator A5019980330 @default.
- W2561652184 creator A5029214522 @default.
- W2561652184 creator A5043574685 @default.
- W2561652184 creator A5056944189 @default.
- W2561652184 date "2017-03-01" @default.
- W2561652184 modified "2023-09-29" @default.
- W2561652184 title "Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis" @default.
- W2561652184 cites W1490013364 @default.
- W2561652184 cites W1500540703 @default.
- W2561652184 cites W1550971105 @default.
- W2561652184 cites W1617328014 @default.
- W2561652184 cites W1946696006 @default.
- W2561652184 cites W1974063087 @default.
- W2561652184 cites W1974217915 @default.
- W2561652184 cites W1977028597 @default.
- W2561652184 cites W1985812659 @default.
- W2561652184 cites W1987420874 @default.
- W2561652184 cites W1992757032 @default.
- W2561652184 cites W1996113429 @default.
- W2561652184 cites W2005947177 @default.
- W2561652184 cites W2009832071 @default.
- W2561652184 cites W2013605324 @default.
- W2561652184 cites W2015042347 @default.
- W2561652184 cites W2019932021 @default.
- W2561652184 cites W2020844317 @default.
- W2561652184 cites W2022295086 @default.
- W2561652184 cites W2022782092 @default.
- W2561652184 cites W2030822991 @default.
- W2561652184 cites W2047316240 @default.
- W2561652184 cites W2050493658 @default.
- W2561652184 cites W2050982599 @default.
- W2561652184 cites W2075039786 @default.
- W2561652184 cites W2078872247 @default.
- W2561652184 cites W2079294136 @default.
- W2561652184 cites W2086694288 @default.
- W2561652184 cites W2087618621 @default.
- W2561652184 cites W2097116748 @default.
- W2561652184 cites W2098923148 @default.
- W2561652184 cites W2099160718 @default.
- W2561652184 cites W2105669432 @default.
- W2561652184 cites W2107328434 @default.
- W2561652184 cites W2109346853 @default.
- W2561652184 cites W2111838078 @default.
- W2561652184 cites W2113144077 @default.
- W2561652184 cites W2114776324 @default.
- W2561652184 cites W2122542252 @default.
- W2561652184 cites W2125435699 @default.
- W2561652184 cites W2127549590 @default.
- W2561652184 cites W2136403658 @default.
- W2561652184 cites W2137391206 @default.
- W2561652184 cites W2140606211 @default.
- W2561652184 cites W2155060392 @default.
- W2561652184 cites W2155798268 @default.
- W2561652184 cites W2168368423 @default.
- W2561652184 cites W2292672476 @default.
- W2561652184 cites W2299202580 @default.
- W2561652184 cites W2315123323 @default.
- W2561652184 cites W2576440140 @default.
- W2561652184 cites W4211174138 @default.
- W2561652184 cites W612173262 @default.
- W2561652184 doi "https://doi.org/10.1016/j.jaac.2016.12.013" @default.
- W2561652184 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28219485" @default.
- W2561652184 hasPublicationYear "2017" @default.
- W2561652184 type Work @default.
- W2561652184 sameAs 2561652184 @default.
- W2561652184 citedByCount "80" @default.
- W2561652184 countsByYear W25616521842017 @default.
- W2561652184 countsByYear W25616521842018 @default.
- W2561652184 countsByYear W25616521842019 @default.
- W2561652184 countsByYear W25616521842020 @default.
- W2561652184 countsByYear W25616521842021 @default.
- W2561652184 countsByYear W25616521842022 @default.
- W2561652184 countsByYear W25616521842023 @default.
- W2561652184 crossrefType "journal-article" @default.
- W2561652184 hasAuthorship W2561652184A5001609083 @default.
- W2561652184 hasAuthorship W2561652184A5003878022 @default.
- W2561652184 hasAuthorship W2561652184A5013953628 @default.
- W2561652184 hasAuthorship W2561652184A5019980330 @default.
- W2561652184 hasAuthorship W2561652184A5029214522 @default.
- W2561652184 hasAuthorship W2561652184A5043574685 @default.
- W2561652184 hasAuthorship W2561652184A5056944189 @default.
- W2561652184 hasConcept C118552586 @default.
- W2561652184 hasConcept C126322002 @default.
- W2561652184 hasConcept C15744967 @default.
- W2561652184 hasConcept C2776412080 @default.
- W2561652184 hasConcept C2776619155 @default.
- W2561652184 hasConcept C2777270317 @default.
- W2561652184 hasConcept C2777393122 @default.
- W2561652184 hasConcept C2778999636 @default.
- W2561652184 hasConcept C2779626651 @default.
- W2561652184 hasConcept C2779727114 @default.
- W2561652184 hasConcept C2780057945 @default.
- W2561652184 hasConcept C2780135775 @default.